SelectQuote IncSLQT
Price$0.43Intrinsic value$7.271590% above price

Qualitative Analysis

Business overview

Business Overview

SelectQuote, Inc. (NYSE: SLQT) is a leading direct-to-consumer (DTC) distribution platform and healthcare services provider in the United States. Founded in 1985 and headquartered in Overland Park, Kansas, the company operates as an intermediary, utilizing proprietary technology, consumer marketing, and a network of trained, licensed agents to help consumers compare and purchase insurance policies. SelectQuote operates through three primary reportable segments: Senior (Medicare Advantage, Medicare Supplement, and other senior-focused plans), Healthcare Services (including SelectRx, a Patient-Centered Pharmacy Home accredited pharmacy), and Life (term life and other life insurance products). Strategically, the company is transitioning from a transactional insurance broker into a holistic healthcare services provider, leveraging its senior customer acquisition engine to cross-sell pharmacy and chronic care management services.

Research as of 20 Jun 2026

Strategic Initiatives

Growth programs, investments, and their expected impact

AI-assisted
SelectQuote LocalExpansion

A franchise model designed to offer senior health and life insurance products through local sales and support, complementing the existing telephonic distribution model.

Expected impact: Provides a cash-efficient opportunity to leverage the company's technology and carrier platform, driving increased scale and creating a recurring royalty stream.

Sign in / Sign up to read more
InvestmentLow level of capital investment from the company.
TimelineLaunched in early 2026 with ongoing expansion.
SelectRx Concierge Medication Adherence ProgramInnovation

An innovative concierge-like service designed to improve medication adherence for polychronic Medicare beneficiaries managing multiple chronic conditions.

Expected impact: Aims to elevate health plan performance, improve HEDIS Star ratings for payer partners, and drive better health outcomes.

Sign in / Sign up to read more
InvestmentNot specified.
TimelineTrialed in 2025, expanding to additional payers in late 2025, and rolling out across the SelectRx platform in 2026.
Capital Structure OptimizationEfficiency

Refinancing of existing debt to extend maturities, lower annual cash debt service, and improve liquidity.

Expected impact: Extends term debt maturity to January 2031, increases seasonal borrowing capacity to $90 million, lowers principal amortization, and provides potential interest rate step-downs of up to 100 basis points.

Sign in / Sign up to read more
InvestmentRefinanced via a $415 million credit facility.
TimelineCompleted in January 2026.

Mergers, Acquisitions & Partnerships

Recent deals and strategic collaborations

AI-assisted

Recent Acquisitions

SelectPatient Management (SPM) Platform$4M

Acquisition of an existing chronic care management platform to launch SelectPatient Management, helping patients navigate and manage chronic conditions using comprehensive treatment plans.

Financial impact: Contributes to the expansion of the rapidly growing Healthcare Services division alongside SelectRx.

Sign in / Sign up to read more

Strategic Partnerships

Bain Capital, Morgan Stanley Private Credit, and Newlight PartnersStrategic Investment / Equity Financing

Provided a $350 million strategic investment to recapitalize the balance sheet, lower annual cash debt service, and fund growth initiatives in senior health and healthcare services.

Terms: $350 million strategic investment, alongside the appointment of Chris Wolfe (Bain Capital) and Srdjan Vukovic (Newlight Partners) to the Board of Directors.

Sign in / Sign up to read more
Major Pharmacy Benefit Manager (PBM) PartnerMulti-year Strategic Agreement

Bolsters financial consistency and stability across both organizations by providing increased visibility and predictability to reimbursement rates for the SelectRx pharmacy.

Terms: Multi-year agreement effective January 1, 2026, offering more predictable economics.

Sign in / Sign up to read more
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.